Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Current Neurovascular Research
|
December 27, 2005
Increased behavioral and histological variability arising from changes in cerebrovascular anatomy of the Mongolian gerbil
David T Laidley, Frederick Colbourne, Dale Corbett
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society
|
April 23, 2016
Multi-modal vertebrae recognition using Transformed Deep Convolution Network
Yunliang Cai, Mark Landis, David T Laidley, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
December 31, 2020
Case series - <sup>18</sup>F-DCFPyL-positron emission tomography/computed tomography (PET/CT) time of imaging
Golmehr Sistani, Ur Metser, Glenn S Bauman, et al.
Current Radiopharmaceuticals
|
February 9, 2022
Toxicity and Tolerability of <sup>177</sup>Lu-DOTA-TATE PRRT with a Modified Administered Activity Protocol in NETs of Variable Origin - A Phase 2 Registry Study
Alireza Khatami, Golmehr Sistani, Duncan E K Sutherland, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2021
Efficacy of <sup>177</sup>Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study
Golmehr Sistani, Duncan E K Sutherland, Amol Mujoomdar, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2024
Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer
Colleen Mackenzie, Jasna Deluce, Morgan Black, et al.
Current Oncology (Toronto, Ont.)
|
February 25, 2025
Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer Centres
Gautham Nair, Morgan Black, Kathie Baer, et al.
Journal of Cancer Research and Clinical Oncology
|
June 10, 2021
Survival predictors of <sup>177</sup>Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)
Mina M Swiha, Duncan E K Sutherland, Golmehr Sistani, et al.
Current Oncology (Toronto, Ont.)
|
March 27, 2024
<sup>177</sup>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice
Kim N Chi, Steven M Yip, Glenn Bauman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2020
Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines
Simron Singh, Emily K Bergsland, Cynthia M Card, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Current Neurovascular Research
|
December 27, 2005
Increased behavioral and histological variability arising from changes in cerebrovascular anatomy of the Mongolian gerbil
David T Laidley, Frederick Colbourne, Dale Corbett
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society
|
April 23, 2016
Multi-modal vertebrae recognition using Transformed Deep Convolution Network
Yunliang Cai, Mark Landis, David T Laidley, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
December 31, 2020
Case series - <sup>18</sup>F-DCFPyL-positron emission tomography/computed tomography (PET/CT) time of imaging
Golmehr Sistani, Ur Metser, Glenn S Bauman, et al.
Current Radiopharmaceuticals
|
February 9, 2022
Toxicity and Tolerability of <sup>177</sup>Lu-DOTA-TATE PRRT with a Modified Administered Activity Protocol in NETs of Variable Origin - A Phase 2 Registry Study
Alireza Khatami, Golmehr Sistani, Duncan E K Sutherland, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2021
Efficacy of <sup>177</sup>Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study
Golmehr Sistani, Duncan E K Sutherland, Amol Mujoomdar, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2024
Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer
Colleen Mackenzie, Jasna Deluce, Morgan Black, et al.
Current Oncology (Toronto, Ont.)
|
February 25, 2025
Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer Centres
Gautham Nair, Morgan Black, Kathie Baer, et al.
Journal of Cancer Research and Clinical Oncology
|
June 10, 2021
Survival predictors of <sup>177</sup>Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)
Mina M Swiha, Duncan E K Sutherland, Golmehr Sistani, et al.
Current Oncology (Toronto, Ont.)
|
March 27, 2024
<sup>177</sup>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice
Kim N Chi, Steven M Yip, Glenn Bauman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 15, 2020
Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines
Simron Singh, Emily K Bergsland, Cynthia M Card, et al.
Page
of 2